Useful Extend-release Chitosan Tablets with High Antioxidant Activity
Open Access
- 27 May 2010
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 2 (2), 245-257
- https://doi.org/10.3390/pharmaceutics2020245
Abstract
The antioxidant properties of different low molecular weight (LMW) chitosans (CS1; 22 kDa, CS2; 38 kDa, CS3; 52 kDa, CS4; 81 kDa) were examined for possible use in extended-release tablets. The criteria used were the ability of the chitosans to reduce Cu2+, and hydroxyl and superoxide radicals and N-centered radicals derived from 1,1'-diphenyl-2-picrylhydrazyl, via the use of ESR spectrometry. CS2 showed the highest scavenging activity. CS1 and CS3, however, were much less effective and CS4 was not a viable antioxidant. The results suggest that CS2 could be useful in combating the development of oxidative stress. A series of chitosan tablets were prepared using a spray drying method and evaluated as an extended-release matrix tablet using theophylline (TPH) as a model drug. The release of TPH from the different MW chitosan tablets increased with increasing MW of the chitosan used. CS2, CS3 and CS4 showed a reasonable release activity, but CS1 showed the shortest release activity. Moreover, the CS2-TPH tablet showed the highest scavenging activity of the three chitosan tablets (CS2-CS4) using 2,2’-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) radicals. These results suggest that a CS2-TPH tablet could be potentially useful in an extended-release matrix tablet with a high antioxidant activity.This publication has 35 references indexed in Scilit:
- In vivo drug release from hydrophilic dextran tablets capable of forming polyion complexJournal of Controlled Release, 2006
- Evaluation of sodium alginate as drug release modifier in matrix tabletsInternational Journal of Pharmaceutics, 2006
- Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in ratsToxicology, 2006
- Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress1,2Free Radical Biology & Medicine, 2002
- Chitosan microspheres prepared by spray dryingInternational Journal of Pharmaceutics, 1999
- Chitosan sponges as sustained release drug carriersInternational Journal of Pharmaceutics, 1997
- Antioxidant Activities of Some Extracts ofThymus zygisFree Radical Research, 1997
- Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group studyEuropean Respiratory Journal, 1996
- Directly compressed tablets containing chitin or chitosan in addition to mannitol.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982